| Link | Hingorani, D. et al. (2022) Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy. Nat Commun. 2022; 13: 3869. | 765312, 765512 | References | |
|
89 KB
|
|
Customer Letter The PreAnalytiX® path for the PAXgene® Blood RNA System transition from the In Vitro Diagnostic Directive (IVDD) to the In Vitro Diagnostic Regulation (IVDR) | 762174, 762165 | Handbooks |
|
422 KB
|
|
Does Stabilization Chemistry Matter? Performance Comparison of PAXgene® and Streck®. Stabilization Blood Collection Tubes for ccfDNA Testing | 768165 | White Papers |
|
896 KB
|
|
Labware List — QIAsymphony PAXgene Blood ccfDNA Kit (SOW-516-8) | 768566 | Supplementary Protocols |
| Link | Meecham, A. et al. (2021) Alternative tissue fixation for combined histopathological and molecular analysis in a clinically representative setting. Histochem Cell Biol. | 765312, 765512 | References | |
|
1 MB
|
|
PAXgene® Blood ccfDNA Tube (CE-IVD) Tube Robustness Studies | 768165 | Technical Notes |
|
1 MB
|
|
PAXgene® Blood ccfDNA Tube (CE-IVD) Plasma and Nucleated Cellular Fraction Stability Study | 768165 | Technical Notes |
|
1 MB
|
|
PAXgene® Blood ccfDNA Tube (CE-IVD) Sample Transportation Study (Summer Profile) | 768165 | Technical Notes |
| Link | Robinson, P. S. et al. (2021) Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. Nat Genet. | 765312, 765512 | References | |
|
6 MB
|
|
Multimodal Analysis of Circulating Cell-free RNA, (ccfRNA), Circulating Cell-free DNA (ccfDNA) and Genomic DNA (gDNA) From Blood Samples Collected in PAXgene Blood ccfDNA Tubes (Ullius, AACR 2020) | 768165 | Posters |
|
7 MB
|
|
Integrated workflow for Blood Collection, ccfDNA Stabilization and Extraction for Non-invasive Prenatal Testing (Ullius, AMP 2016) | 768165 | Posters |
|
5 MB
|
|
Verification of a Complete Sample to Insight Liquid Biopsy Workflow – NGS of ccfDNA From Stabilized Blood (Krenz, AACR 2018) | 768165 | Posters |
|
4 MB
|
|
A Shortened Automated Workflow for Processing Plasma Directly From Primary Blood Collection Tubes Reduces Turnaround Time and Risk of Sample Mix-up in ccfDNA Based Applications (Voss, CNAPS 2017) | 768165 | Posters |
|
3 MB
|
|
Cell-free DNA Quality and Quantity Assessment – A Method Comparison (Ullius, CNAPS 2019) | 768165 | Posters |
|
7 MB
|
|
Performance Evaluation of Collection/Stabilization/Purification Systems for Liquid Biopsy Cancer Biomarker Applications (Groelz, AMP 2017) | 768165 | Posters |